Tim Lohoff PhD
Principal
Slate Medicines is a biotechnology company focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.
$130M
Series A Financing in Slate Medicines to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders
Forbion team
Rogier Rooswinkel PhD
General Partner
Vincent Loon MSc
Business Analyst
Luuk de Vries PhD
Analyst
Nat Kolber PhD
Fellow